Jerome Durso is recorded as CEO at Altimmune, Inc. (ALT) since January 1, 2026 and Board Member at Altimmune, Inc. (ALT) since February 24, 2025. Altimmune, Inc. reported in an 8-K filed December 1, 2025 that Jerome Durso was appointed President and Chief Executive Officer, effective January 1, 2026. Altimmune, Inc. reported in an 8-K filed February 25, 2025 that Jerome Durso was appointed director of the Board, effective February 24, 2025. Jerome Durso has spoken on 1 investor event across 1 company, most recently for Altimmune, Inc. on June 4, 2026. Altimmune, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Altimmune, Inc. includes Vipin K. Garg (CEO), William Enright (CEO), Elizabeth A. Czerepak (CFO) and 7 others.
“Jerome Durso, currently a member of the Company's Board of Directors (the "Board"), has been appointed by the Board to serve as the Company's President and Chief Executive Officer, effective as of the Transition Date.”
Altimmune, Inc. Form 8-K, filed December 1, 2025
· Read the filing
“On February 24, 2025, the Board of Directors (the "Board") of Altimmune, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased its size from eight to ten directors and appointed Teri Lawver and Jerome Durso as directors of the Board.”
Altimmune, Inc. Form 8-K, filed February 25, 2025
· Read the filing
Jerome Durso on recent calls
“Obviously coming off, and I'm sure we'll have a chance during the discussion, an exciting meeting at Easel last week, but really continuing to stay focused and make progress in the areas that we've talked about throughout the last couple of quarters.”
